Vancomycin-induced severe thrombocytopenia in a young infant
Rev. Soc. Bras. Med. Trop
;
51(6): 873-875, Nov.-Dec. 2018. tab, graf
Article
in English
| LILACS
| ID: biblio-977108
ABSTRACT
Abstract Vancomycin is a first-line drug for treating methicillin-resistant Staphylococcus aureus. Thrombocytopenia is a rare adverse reaction to vancomycin treatment, and there are no reports of vancomycin-induced thrombocytopenia (VIT) in infants. We describe the case of a 3-month-old girl who was diagnosed with purulent meningitis. After 13 days of treatment with vancomycin, her platelet count reduced to 8 × 109/L. Vancomycin was discontinued, and intravenous methylprednisolone was administered. The platelet count returned to normal after 4 days. Patients, especially young children, receiving vancomycin for a long clinical course should undergo careful monitoring of laboratory indicators and blood tests.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Thrombocytopenia
/
Vancomycin
Type of study:
Diagnostic study
Limits:
Female
/
Humans
/
Infant
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2018
Type:
Article
Affiliation country:
China
Institution/Affiliation country:
Xiamen Maternity and Child Care Hospital/CN
Similar
MEDLINE
...
LILACS
LIS